ArticleBMC cancer2023

Prediction of residual disease using circulating DNA detection after potentiated radiotherapy for locally advanced head and neck cancer (NeckTAR): a study protocol for a prospective, multicentre trial.

Angeline Ginzac et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.